Several clinical trials have assessed the efficacy of female Viagra gels. One study showed a statistically significant improvement in sexual desire and arousal in a substantial percentage of participants, compared to a placebo group. Specific numbers varied depending on the gel’s formulation and the trial design, but positive results were generally observed for desire and subjective arousal.
Specific Trial Data
Results from a pivotal Phase 3 trial indicated approximately 40% of women using the gel reported increased sexual desire, while roughly 35% experienced enhanced arousal. These improvements were noted alongside a significant increase in satisfying sexual experiences. Importantly, the improvement in sexual function was not solely linked to increased lubrication. The gel’s impact on neurotransmitters possibly contributes to the observed effects on desire.
Considerations and Limitations
Side effects were generally mild and transient, most commonly involving mild headaches or flushing. However, individual responses can vary. It’s vital to consult a healthcare provider to discuss potential risks and benefits, particularly given pre-existing medical conditions. The trials focused primarily on premenopausal women, therefore data on postmenopausal women is limited. Further research is needed to fully understand the long-term effects and suitability across diverse populations.
Further Research
Ongoing research explores different formulations and delivery methods, aiming to improve both efficacy and patient experience. Focus areas include optimizing the gel’s absorption and exploring potential synergistic effects with other therapies for female sexual dysfunction.
